| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.3 | 0.0005 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0005 |